Laura A. Goguen

Neoadjuvant Nivolumab or Nivolumab Plus Ipilimumab in Untreated Oral Cavity Squamous Cell Carcinoma

Jonathan D. Schoenfeld, Glenn J. Hanna, Vickie Y. Jo et al. · JAMA Oncology · 2020 · 326 citations · Full text

Dose to Larynx Predicts for Swallowing Complications After Intensity-Modulated Radiotherapy

Hale Başak Çağlar, Roy B. Tishler, Megan Othus et al. · International Journal of Radiation Oncology*Biology*Physics · 2008 · 230 citations

Radiation Therapy, Pediatric Swallowing, Larynx Predicts +6

Dysphagia after Sequential Chemoradiation Therapy for Advanced Head and Neck Cancer

Laura A. Goguen, Marshall R. Posner, Charles M. Norris et al. · Otolaryngology · 2006 · 104 citations

Preexisting tumor-resident T cells with cytotoxic potential associate with response to neoadjuvant anti–PD-1 in head and neck cancer

Giacomo Oliveira, Ann Marie Egloff, Alexander B. Afeyan et al. · Science Immunology · 2023 · 103 citations · Full text

Neoadjuvant and Adjuvant Nivolumab and Lirilumab in Patients with Recurrent, Resectable Squamous Cell Carcinoma of the Head and Neck

Glenn J. Hanna, Anne O’Neill, Kee‐Young Shin et al. · Clinical Cancer Research · 2021 · 102 citations · Full text